Valeant Pharmaceuticals International (VRX)
Add to Watchlists Create an Alert
74.82
-0.71 -0.94%
NYSE
May 22, 8:00PM
BATS Real time
Currency in USD
Valeant Pharmaceuticals International Net Income Quarterly:
-27.53M for March 31, 2013Valeant Pharmaceuticals International Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -27.53M |
| Dec. 31, 2012 | -89.14M |
| Sept. 30, 2012 | 7.645M |
| June 30, 2012 | -21.61M |
| March 31, 2012 | -12.92M |
| Dec. 31, 2011 | 55.86M |
| Sept. 30, 2011 | 40.86M |
| June 30, 2011 | 56.36M |
| March 31, 2011 | 6.482M |
| Dec. 31, 2010 | -31.13M |
| Sept. 30, 2010 | -207.88M |
| June 30, 2010 | 33.97M |
| March 31, 2010 | -3.15M |
| Dec. 31, 2009 | 73.00M |
| Sept. 30, 2009 | 40.36M |
| June 30, 2009 | 24.09M |
| March 31, 2009 | 39.00M |
| Dec. 31, 2008 | 120.38M |
| Sept. 30, 2008 | 48.44M |
| June 30, 2008 | -25.29M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
VRX Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Actavis | -102.80M |
| Mylan | 106.88M |
| Warner Chilcott | 124.00M |
VRX Net Income Quarterly Rankings
| Overall |
33rd percentile 5291 of 8005 |
| Sector |
10th percentile 615 of 686 in Healthcare |
| Industry |
10th percentile 61 of 68 in Drug Manufacturers - Specialty & Generic |
VRX Net Income Quarterly Range, Past 5 Years
| Minimum | -207.88M | Sep 2010 |
| Maximum | 120.38M | Dec 2008 |
| Average | 6.390M |